TFX Stock Chart & Stats
$2350.00
$0.00(0.00%)
―
--
Day’s Range― - ―
52-Week Range$1,825.00 - $2,442.22
Previous CloseN/A
VolumeN/A
Average Volume (3M)0.00
Market Cap
$102.25B
Enterprise Value$7.66K
Total Cash (Recent Filing)$309.41M
Total Debt (Recent Filing)$2.69B
Price to Earnings (P/E)―
Beta-0.08
Next Earnings
Aug 06, 2026EPS Estimate
22.2Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-22.80
Shares Outstanding44,270,210
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)1.74
Price to Sales (P/S)2.73
P/FCF Ratio22.19
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$2,619.76Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering8
EPS Forecast (FY)117.03
Revenue Forecast (FY)$40.06B
TFX FAQ
What was Teleflex’s price range in the past 12 months?
Teleflex lowest stock price was $1825.00 and its highest was $2442.22 in the past 12 months.
What is Teleflex’s market cap?
Teleflex’s market cap is $102.25B.
When is Teleflex’s upcoming earnings report date?
Teleflex’s upcoming earnings report date is Aug 06, 2026 which is in 12 days.
How were Teleflex’s earnings last quarter?
Teleflex released its earnings results on May 07, 2026. The company reported $24.337 earnings per share for the quarter, beating the consensus estimate of $21.256 by $3.082.
Is Teleflex overvalued?
According to Wall Street analysts Teleflex’s price is currently Undervalued.
Does Teleflex pay dividends?
Teleflex does not currently pay dividends.
What is Teleflex’s EPS estimate?
Teleflex’s EPS estimate is 22.2.
How many shares outstanding does Teleflex have?
Teleflex has 44,270,210 shares outstanding.
What happened to Teleflex’s price movement after its last earnings report?
Teleflex reported an EPS of $24.337 in its last earnings report, beating expectations of $21.256. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Teleflex?
Currently, no hedge funds are holding shares in MX:TFX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Teleflex Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$2,619.76 (― Downside)
$2,619.76 (― Downside)
Blogger Sentiment
Bullish
MX:TFX Sentiment 70%
Sector Average 65%
Sector Average 65%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
13.15%
12-Months-Change
Fundamentals
Return on Equity
1.02%
Trailing 12-Months
Asset Growth
-5.31%
Trailing 12-Months
Company Description
Teleflex
Teleflex Incorporated is a global medical technology company dedicated to designing, developing, manufacturing, and distributing single-use medical devices. These products are crucial for diagnostic and therapeutic procedures, particularly within critical care and surgical environments worldwide. Its comprehensive product portfolio includes: Vascular Access Solutions: Featuring the "Arrow" brand, these include catheters, advanced catheter navigation and tip positioning systems, and intraosseous access systems. They are essential for administering intravenous therapies, monitoring blood pressure, and drawing blood samples, all achievable through a single access point. Interventional Cardiology & Radiology Products: This segment covers various coronary catheters, therapies for structural heart conditions, and devices for peripheral intervention and cardiac assist. Key users include interventional cardiologists, radiologists, and vascular surgeons. Specific offerings comprise Arrow, Guideline, and Trapliner catheters, the Manta Vascular Closure Device, and Arrow Oncontrol systems. Anesthesia and Surgical Products: The company provides anesthesia and pain management products, serving hospitals, emergency medical services, and military health organizations. Its surgical division offers metal and polymer ligation clips, fascial closure systems for laparoscopic procedures, percutaneous surgical systems, and a range of other surgical instruments. Interventional Urology & General Urology: Teleflex's interventional urology offerings prominently feature the UroLift System, an innovative treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH). Additionally, it supplies general urology products like catheters, urine collection devices, catheterization accessories, and tools for operative endourology, alongside providing bladder management services. Respiratory Care Products: This category includes oxygen and aerosol therapy devices, spirometry equipment, and ventilation management systems, applicable across diverse healthcare settings. Teleflex serves a broad customer base, encompassing hospitals, healthcare providers, medical device manufacturers, and the home care market. Established in 1943, the company maintains its headquarters in Wayne, Pennsylvania.
TFX Stock 12 Month Forecast
Average Price Target
$2,619.76